Endoscopy Unit, Department of Internal Medicine, College of Medicine, Prince Sattam Bin, Abdulaziz University, PrinceSattam Bin Abdulaziz University Hospital, Al-Kharj 16278, Saudi Arabia.
Department of Gastroenterology, Prince Sultan Military Medical City, Riyadh 11159, Saudi Arabia.
Curr Oncol. 2023 Sep 11;30(9):8338-8351. doi: 10.3390/curroncol30090605.
(1) Background: Saudi Arabia (SA) is a country with a low incidence of gastric cancer (GC). In this study, we sought to assess the epidemiology of GC, its clinicopathological profiles, and its association with risk factors as well as to identify premalignant gastric lesions (PGL) and examine neoplastic progression. (2) Methods: This five-year prospective study screened for GC and PGL in asymptomatic Saudi patients, aged 45-75 years (n = 35,640) and living in Al Kharj, Riyadh province in central SA. Those who were positive in a high-sensitivity guaiac fecal occult blood test (HSgFOBT+) and had negative results in colonoscopy offered to undergo upper GI endoscopy (n = 1242). Factors associated with GC were examined. (3) Results: The five-year participation rate was 87% (1080/1242). The incidence rate of GC was 26.9 new cases per 100,000 population per year (9.6 new cases per year/total population at risk-35,640), and it was 8.9 cases per 1000 persons per year among the 1080 subjects with HSgFOBT+ and negative colonoscopy results. The five-year mortality rate was 67% among patients with GC (n = 48), 3.0% among participants in the gastric screening program (n = 1080) and 0.09% among the original population participating in the colorectal screening program (n = 35,640). Intestinal-type adenocarcinoma was the most frequent type (77%), with the tumor most commonly located in the antrum (41%). Overall, 334 participants had PGL, and seven of them (2.1%) showed neoplastic progression to GC during the follow-up. Factors associated with GC were age, Helicobacter pylori (HP) infection, obesity (body mass index BMI > 30), smoking, a diet of salty preserved foods, low income and a family history of GC. (4) Conclusions: The incidence of GC is low in central SA, but screening for PGL and GC among patients with HSgFOBT+ and negative colonoscopy may prevent or result in the early treatment of GC. HP eradication, normal body weight, not smoking and adhering to a healthy diet can reduce the risk of GC. The resulting data provide important input for the improvement of national guidelines.
(1)背景:沙特阿拉伯(SA)是胃癌(GC)发病率较低的国家。在这项研究中,我们旨在评估 GC 的流行病学、临床病理特征及其与危险因素的关系,以及识别癌前胃病变(PGL)并检查肿瘤进展情况。
(2)方法:这项为期五年的前瞻性研究筛查了无症状的沙特患者中的 GC 和 PGL,年龄在 45-75 岁之间(n=35640),居住在沙特中部的哈里吉省。那些在高灵敏度愈创木脂粪便潜血试验(HSgFOBT+)中呈阳性且结肠镜检查结果为阴性的患者(n=1242)接受上胃肠道内镜检查。检查了与 GC 相关的因素。
(3)结果:五年的参与率为 87%(1080/1242)。GC 的发病率为每年每 10 万人中有 26.9 例新发病例(每年 9.6 例/总风险人群-35640),在 1242 例 HsgFOBT+和阴性结肠镜检查结果的患者中,每年每 1000 人中就有 8.9 例。GC 患者的五年死亡率为 67%(n=48),胃筛查计划参与者为 3.0%(n=1242),参加结直肠筛查计划的原始人群为 0.09%(n=35640)。肠型腺癌是最常见的类型(77%),肿瘤最常见于胃窦(41%)。总体而言,334 名参与者有 PGL,其中 7 名(2.1%)在随访期间出现向 GC 的肿瘤进展。与 GC 相关的因素是年龄、幽门螺杆菌(HP)感染、肥胖(体重指数 BMI>30)、吸烟、食用咸腌食品、低收入和 GC 家族史。
(4)结论:沙特中部的 GC 发病率较低,但对 HsgFOBT+和阴性结肠镜检查的患者进行 PGL 和 GC 筛查可能会预防或导致 GC 的早期治疗。HP 根除、正常体重、不吸烟和坚持健康饮食可以降低 GC 的风险。由此产生的数据为国家指南的改进提供了重要依据。